Resources · September 29, 2026
What Causes Implied Volatility Spikes in Stocks?
A stock can be quiet for weeks, then its option premium jumps before the chart shows a meaningful move. For a premium seller, that is the moment to ask: what causes implied volatility spikes, and is the higher credit actually compensating for a risk the market sees before you do?
Implied volatility is not a prediction of direction. It is the options market's estimate of how widely the underlying could move over a defined period. When that estimate rises sharply, option prices rise with it. The reason may be a scheduled catalyst, a developing headline, aggressive demand for protection, or a market-wide change in risk appetite.
The distinction matters. A high-IV setup can be a valid premium-selling opportunity, but only after you identify whether the volatility is broad, temporary, and well understood or tied to a stock-specific event that can permanently reprice the underlying.
What causes implied volatility spikes?
Implied volatility spikes when buyers and sellers of options suddenly assign a higher probability to larger future price moves. That can happen because new information changes expectations, because an event is approaching, or because options demand overwhelms available supply at particular strikes and expirations.
The options market does not need certainty to raise IV. It only needs uncertainty. A company facing a binary legal ruling, for example, may have no new fundamental news on a given morning. But if the ruling is expected before an option expires, traders may pay more for puts and calls because the range of possible outcomes is wider than normal.
For short-option traders, the key question is not simply whether IV is elevated. It is whether the market is pricing a known risk appropriately, underpricing it, or reacting to a risk that still lacks clear boundaries.
Scheduled events create measurable uncertainty
Earnings are the most familiar cause of an implied volatility spike. As the reporting date approaches, options begin pricing the possibility of a gap higher or lower after results, guidance, and the conference call. IV often reaches a local peak immediately before the release, then drops sharply afterward once the event is resolved. This is the classic volatility crush.
But earnings are only one calendar risk. Other scheduled events can produce the same pattern, sometimes with less obvious timing:
- FDA decisions, clinical-trial data, advisory committee meetings, and regulatory deadlines
- Court hearings, patent decisions, antitrust rulings, and major settlement dates
- Investor days, product launches, shareholder votes, and lockup expirations
- SEC filing deadlines, delayed financial statements, and exchange-compliance updates
A planned event may be fully visible to the market while still being dangerous for a short strangle, cash-secured put, or credit spread. Knowing the date is not the same as knowing the distribution of outcomes. The market can price a 10% expected move and still be wrong by a wide margin.
Unscheduled news can reprice the stock faster than models
The most damaging IV spikes often begin without a clean calendar entry. A surprise SEC investigation, accounting allegation, executive departure, cybersecurity incident, product recall, acquisition rumor, or adverse legal development can force traders to reassess both the near-term move and the company's longer-term value.
This is why a high IV rank alone is not a trade thesis. A stock may look statistically expensive relative to its own history because options traders are responding to information that has not yet reached every retail workflow. In these situations, selling premium can mean taking the other side of informed demand for protection.
The same principle applies to headline-sensitive industries. Drug developers, banks, defense contractors, energy producers, and large technology companies can all carry event risks that do not fit neatly into an earnings calendar. The relevant question is whether something could happen before your expiration that changes the stock's price regime.
Positioning and liquidity can amplify volatility
Fundamental uncertainty is not the only driver. Market mechanics can make an IV spike larger and faster than the underlying news appears to justify.
When institutions rush to buy downside puts, market makers typically hedge by selling stock or stock futures. That hedging flow can add pressure to the underlying, which increases demand for more puts and lifts implied volatility further. The feedback loop is especially visible in stressed markets and heavily traded names.
A crowded call market can create a different version of the same dynamic. If customers buy large volumes of calls, dealers may need to buy shares to hedge. The stock can rise, short-dated call IV can jump, and the implied distribution can become skewed toward an upside move. This does not guarantee a squeeze, but it changes the risk profile of covered calls and call credit spreads.
Liquidity matters as well. Wide bid-ask spreads, thin open interest, and concentrated order flow can produce apparent IV spikes that are partly a pricing artifact. A single aggressive order in an illiquid expiration may print at a high implied volatility without representing a broad market consensus. Before treating IV as a signal, check whether it is supported by meaningful volume, open interest, and executable quotes.
Skew reveals where traders fear the move
An overall IV number can hide the more useful detail. Skew shows how implied volatility differs across strikes. In many equities, out-of-the-money puts carry higher IV than comparable calls because traders pay a premium for downside protection.
When put skew steepens sharply, the market may be pricing increased crash or gap risk. When call-side IV becomes unusually elevated, traders may be positioning for an upside catalyst, a takeover possibility, or a squeeze scenario. Neither condition tells you what will happen. Both tell you that a simple delta-based probability can be less reliable than it appears.
For premium sellers, strike-specific IV matters more than a single headline metric. A 20-delta put may offer an attractive credit because downside demand is intense, not because the strike is comfortably safe.
Macro shocks lift volatility across many names
Sometimes the catalyst is not the company at all. Inflation data, Federal Reserve decisions, employment reports, geopolitical escalation, credit stress, tariff announcements, or an abrupt move in Treasury yields can raise index volatility and pull individual-stock IV higher.
Correlation tends to rise when markets are under pressure. Stocks that normally trade on their own earnings outlook can begin moving together as traders reduce risk. This matters for traders who believe diversification across several short puts or credit spreads eliminates exposure. If the positions share the same macro sensitivity, a market-wide volatility shock can hurt all of them at once.
Sector-specific macro risk also matters. A change in oil prices can alter energy-stock IV. Rate expectations can move bank, REIT, and growth-stock options. Drug-pricing policy can affect healthcare names. Broad volatility may be the backdrop, but the strongest spike can still occur in the stocks with direct exposure.
Why IV spikes can persist after the first headline
A common mistake is assuming volatility should collapse as soon as news breaks. It often does after a clean, resolved event such as earnings. But IV can remain elevated when the first headline creates a chain of unanswered questions.
Consider a company disclosing a regulatory inquiry. The initial announcement may be only the beginning. Traders may then need to assess potential fines, operating restrictions, restated financials, litigation, leadership changes, and the timing of future disclosures. IV remains high because uncertainty remains high.
Duration is central. A one-day shock and a three-month investigation should not be evaluated with the same short-premium framework. Near-dated options may decay quickly after the first reaction, while longer-dated options retain elevated IV because the ultimate catalyst window is still open.
A pre-trade workflow for volatility spikes
Before selling elevated premium, start with the expiration date, not the premium. Identify every known catalyst that can occur before that expiry, then determine whether the option market is pricing a routine event or a potentially discontinuous one.
Review the expected move and compare it with the stock's prior reactions to similar events. Historical moves are not a ceiling, especially when the business, macro setting, or event severity has changed, but they provide useful context. Then inspect IV term structure. If the expiration containing the event is much richer than expirations before or after it, the market is isolating a specific risk window.
Next, look at skew, unusual options volume, and quote quality. Is downside protection being bought aggressively? Is one strike or expiry attracting abnormal activity? Are spreads so wide that the displayed credit overstates what you can realistically capture? These details often explain why a trade looks attractive on a scanner but carries more tail risk than expected.
Finally, match structure to the risk you found. Defined-risk spreads can limit damage from an event that cannot be avoided. Wider strikes or smaller size may be appropriate when the thesis is sound but uncertainty is elevated. Passing on the trade is appropriate when the catalyst cannot be bounded. No amount of theta makes an unquantified gap risk disappear.
TickerRisk is built around this pre-trade question: what can disrupt this position before the selected expiry? A disciplined scan of earnings, filings, regulatory developments, option activity, and company-specific signals is more useful than discovering the catalyst after premium has already been sold.
High implied volatility is not automatically a warning, and low implied volatility is not automatically safe. The edge comes from separating ordinary uncertainty from hidden event risk, then deciding whether the credit is enough for the risk you are actually taking.
TickerRisk scores any S&P 500 ticker for earnings, FDA, legal & SEC catalysts in your expiry window — free, no login required.
Open the scanner